Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000701253 | SCV000830044 | likely benign | Atrial fibrillation, familial, 6 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000780552 | SCV000917913 | likely benign | not specified | 2017-11-06 | criteria provided, single submitter | clinical testing | Variant summary: The NPPA c.352C>A (p.Leu118Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. 2/4 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index). This variant was found in 54/275440 control chromosomes in gnomAD at a frequency of 0.000196, which is approximately 20 times the estimated maximal expected allele frequency of a pathogenic NPPA variant (0.00001), suggesting this variant is likely a benign polymorphism. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories; nor evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as likely benign. |
Breakthrough Genomics, |
RCV001535777 | SCV005256894 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome |
RCV001535777 | SCV001749931 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Likely benign and reported on 06-13-2019 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. |